Friederike Holze
Postdoctoral Fellow at Copenhagen University Hospital
Data updated
Research Footprint
Friederike Holze appears in 36 tracked papers (2019–2026), most studied alongside LSD, Psilocybin and MDMA, across Healthy Volunteers, Anxiety Disorders and Depressive Disorders.
Most-cited paper: Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness A randomized, double-blind, placebo-controlled Phase II study (285 citations).
Frequent co-authors: Matthias Liechti, Patrick Vizeli and Lukas Ley.
Publication Landscape
How the 36 papers Blossom tracks for Friederike Holze line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Friederike Holze's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 36 of 36 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Friederike Holze publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Friederike Holze publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Dr. Friederike Holze is a researcher dedicated to understanding the pharmacology of psychedelics in humans. Her work at the University of Basel and Copenhagen University Hospital focuses on dose-finding studies and the safety and efficacy of LSD. She utilizes PET and fMRI to map the effects of these substances on brain activity and has supervised hundreds of controlled psychedelic sessions.
Key Impact
Specializes in the clinical pharmacology and dose-response dynamics of LSD and other classic psychedelics.
Collaboration Network
44 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Friederike Holze's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Friederike Holze is associated with.